Drugs / Plant Sterol
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT00145717 | Apr → Jul 2005 | cardiovascular disorder, hyperlipoproteinemia | The George Institute | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT04030247 | Jan 2020 → Mar 2021 | — | Stanford University | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | plant sterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00145717 ↗ |